Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Surgical Pathology|March 11, 2026
Clinicopathological and Molecular Features of Glycogen-Rich Breast CarcinomaBurcu Karadal-Ferrena, James P Solomon, Neal Lindeman, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosisAlexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
Journal of Visualized Experiments : Jove|July 24, 2023
Tracking Tumor Cell Dissemination from Lung Metastases Using PhotoconversionMadeline Friedman-DeLuca, Prachiben P Patel, Burcu Karadal-Ferrena, et al.
Molecular Cancer Therapeutics|October 23, 2023
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable PrognosisAlexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
NPJ Breast Cancer|June 13, 2023
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapyGina Kim, Burcu Karadal-Ferrena, Jiyue Qin, et al.
NPJ Breast Cancer|January 6, 2026
Racial disparity in pro-metastatic tumor microenvironment in treatment naïve breast cancerPriyanka Parmar, Burcu Karadal-Ferrena, Suryansh Shukla, et al.
Cell Reports|October 27, 2023
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistanceAnastasia-Maria Zavitsanou, Ray Pillai, Yuan Hao, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancerRay Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Science Advances|March 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancerRay Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growthAli Rashidfarrokhi, Ray Pillai, Yuan Hao, et al.
Pageof 2